Board Member
Solid Biosciences Inc. (SLDB)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Ilan Ganot is recorded as Board Member at Solid Biosciences Inc. (SLDB). Solid Biosciences Inc. reported in an 8-K filed April 10, 2026 that Ilan Ganot was appointed Class I Director, effective April 10, 2026. Solid Biosciences Inc. reported in an 8-K filed April 10, 2026 that Ilan Ganot resigned as member of the Board, effective April 10, 2026. Solid Biosciences Inc. reported in an 8-K filed December 5, 2022 that Ilan Ganot resigned as Chief Executive Officer and President, effective December 2, 2022. Equibles holds 4 filed executive changes naming Ilan Ganot; each is listed under recent activity with its source filing. The proxy statement of Solid Biosciences Inc. reports total compensation of $2,205,508 for Ilan Ganot in fiscal 2022, including a base salary of $532,589. Disclosed compensation is on record for 5 fiscal years. Ilan Ganot has spoken on 3 earnings calls across 1 company, most recently for Solid Biosciences Inc. on April 27, 2022.
“Effective simultaneously with Mr. Ganot's resignation, the Board decreased the number of Class III directors to three, increased the number of Class I directors to three and appointed Mr. Ganot to fill the vacancy in Class I (with a term expiring at the Company's 2028 Annual Meeting of Stockholders).”
“effective at 4:00 p.m., Eastern Time, on April 10, 2026, Ilan Ganot, a member of the Board who was serving in Class III (which class will be up for election at the Company's 2027 Annual Meeting of Stockholders), resigned from the Board.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Recorded current and former roles; source labels appear when available.
2026-04-10–present
2026-04-10–2026-04-10
Start not stated–2026-04-10
Start not stated–2022-12-02
Recorded roles and call appearances connecting this person to public companies.
Board Member
2026-04-10–present
Other people whose current roles at this company are on record from its filings.
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2022 | Solid Biosciences Inc. (SLDB) | Former President and Chief Executive Officer | $532,589 | $2,205,508 |
| 2021 | Solid Biosciences Inc. (SLDB) | Former President and Chief Executive Officer | $551,100 | $3,293,809 |
| 2020 | Solid Biosciences Inc. (SLDB) | President and Chief Executive Officer | $535,000 | $1,481,002 |
| 2019 | Solid Biosciences Inc. (SLDB) | President and Chief Executive Officer | $520,000 | $3,335,929 |
| 2018 | Solid Biosciences Inc. (SLDB) | President and Chief Executive Officer | $450,000 | $5,983,770 |
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.
